
The operating margin in Danish hearing device group William Demant has dropped from about 25 % to about 20 % in recent years, caused partly by a move into the retail market, where margins are generally lower, just as the company has made significant investments in the implant market through Oticon Medical. Medwatch sat down for an interview with CEO Niels Jacobsen at the recent EUHA conference in Nurnberg, Germany.
How would you describe the competition between “the big six” at present?
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app